Achilles therapeutics added to the nasdaq biotechnology index

London, dec. 20, 2021 (globe newswire) -- achilles therapeutics plc (nasdaq: achl), a clinical-stage biopharmaceutical company developing precision t cell therapies to treat solid tumors, today announced that the company has been added to the nasdaq biotech index (nasdaq: nbi), effective prior to market open today, monday, december 20, 2021.
ACHL Ratings Summary
ACHL Quant Ranking